TAIYO Pharma Tech

TAIYO Pharma Tech is a Japanese contract development and manufacturing organization (CDMO) that provides comprehensive services for the pharmaceutical industry. Established in 2019 following the acquisition of Takeda Pharmaceutical's Takatsuki plant by Taiyo Holdings, the company specializes in the manufacturing of various drug forms, including solid dosages and injectables. They offer end-to-end support from formulation development and clinical trial material production to full-scale commercial manufacturing and packaging. The company leverages its high-standard facilities and extensive experience in quality control to serve global pharmaceutical clients.